We recently made a list of UBS’ Bottom Quant Stocks In AI, IT, Healthcare & Others: 29 Stocks In All Sectors. In this piece, ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $79.5, a high estimate of $82.00, ...

Henry Schein is a Fortune 500 company and one of the global leaders in its industry, providing healthcare solutions, as well as the distribution of medical, dental, and veterinary supplies.

Henry Schein ( (HSIC) ) has released its Q3 earnings. Here is a breakdown of the information Henry Schein presented to its investors. Henry ...

On Tuesday, Henry Schein Inc. (NASDAQ:HSIC) reported a third-quarter adjusted EPS of $1.22, down 7.6% year-over-year, beating ...

Q3 2024 Earnings Call Transcript November 5, 2024 Henry Schein, Inc. beats earnings expectations. Reported EPS is $1.22, ...

Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael ...

The dental supplies firm raised the lower end of its 2024 adjusted earnings projection, and now anticipates a range between $4.74 and $4.82 a share, compared with the prior $4.70-to-$4.82 a share ...

Despite modest sales growth, Henry Schein Inc (HSIC) boosts EPS guidance and expands its global e-commerce platform.

Analysts' ratings for Henry Schein (NASDAQ:HSIC ... products and services primarily to office-based dental and medical practitioners, as well as alternate sites of care. The company operates ...